| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.005 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.006 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.006 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.007 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.091 | 0.007 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.009 |